Expectations trend
FY2028 · fiscal year ending 2028-09-30 · fmp
$15.83 → $15.83 · observed estimates
IES Holdings, Inc. (IESC)
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-11-04
$169.07-16.87%
Close 2026-11-04 · 1-day change
NASDAQIndustrialsEngineering & ConstructionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
15.83 → 15.83 EPS · FY ending Sep 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for IESC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Capital spending at least $31.8M in Q3 2026 | The company raised capital spending to support growth. | Intact | CAPEX falls below $25M in Q3 2026 | Capital expenditures: $44.642M FY2026-Q3; GAAP. Published target: CAPEX >= $31.8M. Target period is not explicitly aligned with this observation. Jul 31, 202644,642,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “We added a 176,000 square foot production facility in Abilene, TX to our Infrastructure Solutions business, while continuing to invest meaningful capital into our newly acquired Gulf Island operation in Louisiana to expand its capabilities to manufacture new products.” “While our near-term focus is to prioritize capital spending for organic growth, we continue to evaluate acquisition opportunities, particularly those that will expand our capacity and capabilities to serve our current customers.”” |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-30 · fmp
$15.83 → $15.83 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 20, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a durable compounder with a focus on growth. The current thesis state is intact, supported by strong recent financial performance and management's commitment to expanding capacity and capabilities.
The market seems to have priced in a cheap valuation compared to peers, with a notable expectations gap. However, the fragility of earnings quality suggests that investors are cautious about potential execution risks.
Fundamentals are likely to remain strong in the near term, driven by management's focus on key segments and significant backlog growth. However, there is a high risk factor, as the company has a history of earnings surprises trending down.
The long-term thesis hinges on the performance of sector bellwethers and IESC's ability to maintain guidance. Positive momentum from industry leaders could support IESC, while any negative guidance from these companies could impact its performance.
Overall, IESC is positioned for growth but faces risks from sector dynamics and execution quality. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
EPS near $20 for fiscal 2026 and rising | A primary condition in IES Holdings, Inc.'s published investment case. The stated target is EPS >= $19.69. | Broken | EPS falls below $17 next fiscal year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth of about 24% next fiscal year | IES Holdings grows revenue about 24% next year. | Improving | YoY revenue growth falls below 15% next fiscal year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$7.46B → $7.46B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-01 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-02 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-03 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-04 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-05 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-06 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-07 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-08 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-09 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-10 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-11 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-12 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-13 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-14 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-15 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-16 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-17 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-18 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-19 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-20 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-21 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-22 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-23 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-24 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-25 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-26 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-27 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-28 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-29 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-30 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-10-31 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-11-01 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-11-02 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-11-03 | $15.83 | $7,457,000,000 | 1 / 1 |
| 2026-11-04 | $15.83 | $7,457,000,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.